• 1
    National Centre in HIV Epidemiology and Clinical Research. Australian NSP Survey National Data Report 2003-2007. Sydney ( AUST ) : University of New South Wales; 2008.
  • 2
    Aceijas C, Stimson GV, Hickman M, Rhodes T. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS. 2004;18:2295303.
  • 3
    Law MG, Batey RG. Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase. Med J Aust. 2003;178(5):1978.
  • 4
    Department of Health and Ageing. Return on Investment in Needle and Syringe Programs in Australia. Canberra ( AUST ) : Commonwealth of Australia; 2002.
  • 5
    Wodak A, Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Subst Use Misuse. 2006;41(6):777813.
  • 6
    NSW Government. NSW Drug Summit 1999: Government Plan of Action. Sydney ( AUST ) : New South Wales Health; 1999.
  • 7
    Van Beek I. The Sydney medically supervised injecting centre: a clinical model. Journal of Drug Issues. 2003;33(3):62538.
  • 8
    National Centre in HIV Epidemiology and Clinical Research: Sydney Medically Supervised Injecting Centre Evaluation Report 4: Evaluation of Service Operation and Overdose-related Events. Sydney ( AUST ) : University of New South Wales; 2007.
  • 9
    HIV testing among populations at risk for HIV infection–nine states, November 1995-December 1996: MMWR Morb Mortal Wkly Rep. 1998;47:108691.
  • 10
    UK Collaborative Group for HIV and STI Surveillance. Testing Times - HIV and Other Sexually Transmitted Injections in the United Kingdom. London ( UK ) : Health Protection Agency, Centre for Infection; 2007.
  • 11
    Centres for Disease Control and Prevention. HIV/AIDS Surveillance Report 2001. HIV/AIDS Surveill Rep. 2001;13(1).
  • 12
    National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, Viral Hepatitis and Sexually Transmissible Infections in Australia - Annual Surveillance Report 2007. Canberra ( AUST ) : Australian Institute of Health and Welfare: 2007.
  • 13
    De Irala J, Bigelow C, McCusker J, Hindin R, Zheng L. Reliability of self-reported human immunodeficiency virus risk behaviours in a residential drug treatment population. Am J Epidemiol. 1996;143(7):72532.